Dr Reddys Laboratories (RDY) Profit After Tax (2009 - 2026)
Dr Reddys Laboratories' Profit After Tax came in at $45.93 million for the quarter ended Jun 30, 2026, down 72.1% from $164.71 million a year earlier but up 90.4% from the prior quarter.
Dr Reddys Laboratories (RDY) Profit After Tax (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported Profit After Tax of $367.21 million, down 45.6% year-over-year; for the year ended Mar 31, 2026, it came in at $452 million, down 33.5% from the prior year.
- Profit After Tax carries a five-year compound annual growth rate of 13.9% (years ended Mar 2021 to Mar 2026).
- Going back by year, Profit After Tax was $679.6 million in the year ended Mar 31, 2025 (+1.7%), $668 million in the year ended Mar 31, 2024 (+21.9%), $548 million in the year ended Mar 31, 2023 (+76.2%) and $311 million in the year ended Mar 31, 2022 (+31.8%).
- The five-year range for quarterly Profit After Tax is $11.64 million (the quarter ended Mar 31, 2022) to $183.3 million (the quarter ended Mar 31, 2025).
- Year-over-year, Profit After Tax has declined for three consecutive quarters, with an average decline of 21.4% over the last eight quarters.
- The fastest year-over-year change in Profit After Tax over five years came in the quarter ended Dec 31, 2022 (growth of 143.8%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 86.8%).
- Business Quant data shows RDY's Profit After Tax at $24.12 million (quarter ended Mar 31, 2026), $133.59 million (quarter ended Dec 31, 2025) and $163.58 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 5.28 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.09 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.40 Bn | 396.53 Mn | 45.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.93 Mn |
| Mar 31, 2026 | 24.12 Mn |
| Dec 31, 2025 | 133.59 Mn |
| Sep 30, 2025 | 163.58 Mn |
| Jun 30, 2025 | 164.71 Mn |
| Mar 31, 2025 | 183.30 Mn |
| Dec 31, 2024 | 166.26 Mn |
| Sep 30, 2024 | 160.17 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | 157.38 Mn |
| Dec 31, 2023 | 165.60 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 170.00 Mn |
| Mar 31, 2023 | 169.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 Mn |
| Jun 30, 2022 | 154.01 Mn |
| Mar 31, 2022 | 11.64 Mn |
| Dec 31, 2021 | 48.00 Mn |
| Sep 30, 2021 | 93.00 Mn |
Dr Reddys Laboratories Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();